PBX1 and leukemia: As in the case of the ETV6-RUNX1 fusion, the frequency of newborns carrying the t(1;19) chromosomal translocation (≈0.6%) exceeds the corresponding E2A-PBX1 + leukemia incidence (∼0.002%) [10].